BIOMAT Database Logo BIOMAT Database Logo

In vitro and ex vivo anti-human immunodeficiency virus (HIV) activities of a new water-soluble HIV protease inhibitor, R-87366, containing (2S,3S)-3-amino-2-hydroxy-4-phenylbutanoic acid. 1997

T Komai, and R Yagi, and H Suzuki-Sunagawa, and M Sakurai, and S Higashida, and M Sugano, and H Handa, and H Mohri, and A Yasuoka, and S Oka, and Y Yabe, and T Nishigaki, and S Kimura, and K Shimada
Biological Research, Laboratory, Sankyo Co., Ltd., Tokyo, Japan.

In a series of compounds containing (2S,3S)-3-amino-2-hydroxy-4-phenylbutanoic acid (AHPBA), a transitionstate mimetic, R-87366:(2S,3S)-3-[N-(quinoxaline-2-carbonyl)-L-asparaginyl]amino- 2-hydroxy-4-phenylbutanoyl-L-proline tert-butylamide, was found to be a potent human immunodeficiency virus protease inhibitor (Ki value was 11 nM) and anti-HIV agent (IC90 value was 0.5 microM for HIV-1IIIB acutely infected cells) with moderate water-solubility (4.2 mg/ml at 25 degrees C). The compound was also active in chronically infected Molt-4/HIV-1IIIB cells, and inhibited the proteolytic processing of p55 into p17, suggesting that its anti-HIV activity was derived from HIV protease inhibition. The compound showed more potent activity (IC90 value was 0.03-0.25 microM) against clinical isolates of HIV in 5 out of 6 patients examined with varying clinical status in an ex vivo assay. One isolate, however, from the sixth patient, was less sensitive to R-87366 (IC90 value was 0.5 microM). In experiments with this strain, R-87366 showed comparatively low efficacy in acutely infected peripheral blood mononuclear cell (PBMC). This result suggests that the diversity of sensitivity shown in the ex vivo assay could be caused by the viral property itself. As a result of the determination of nucleic acid sequences in the clinical isolates, some amino acids were found to be substituted in the protease region, in contrast to the HIV-1 clade B consensus sequence, and some of them have been reported to contribute to the susceptibility of HIV protease inhibitors.

UI MeSH Term Description Entries
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D010654 Phenylbutyrates Derivatives of 4-phenylbutyric acid, including its salts and esters.
D011810 Quinoxalines Quinoxaline
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000595 Amino Acid Sequence The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION. Protein Structure, Primary,Amino Acid Sequences,Sequence, Amino Acid,Sequences, Amino Acid,Primary Protein Structure,Primary Protein Structures,Protein Structures, Primary,Structure, Primary Protein,Structures, Primary Protein
D001483 Base Sequence The sequence of PURINES and PYRIMIDINES in nucleic acids and polynucleotides. It is also called nucleotide sequence. DNA Sequence,Nucleotide Sequence,RNA Sequence,DNA Sequences,Base Sequences,Nucleotide Sequences,RNA Sequences,Sequence, Base,Sequence, DNA,Sequence, Nucleotide,Sequence, RNA,Sequences, Base,Sequences, DNA,Sequences, Nucleotide,Sequences, RNA
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human
D017320 HIV Protease Inhibitors Inhibitors of HIV PROTEASE, an enzyme required for production of proteins needed for viral assembly. HIV Protease Inhibitor,Inhibitor, HIV Protease,Inhibitors, HIV Protease,Protease Inhibitor, HIV,Protease Inhibitors, HIV
D017386 Sequence Homology, Amino Acid The degree of similarity between sequences of amino acids. This information is useful for the analyzing genetic relatedness of proteins and species. Homologous Sequences, Amino Acid,Amino Acid Sequence Homology,Homologs, Amino Acid Sequence,Homologs, Protein Sequence,Homology, Protein Sequence,Protein Sequence Homologs,Protein Sequence Homology,Sequence Homology, Protein,Homolog, Protein Sequence,Homologies, Protein Sequence,Protein Sequence Homolog,Protein Sequence Homologies,Sequence Homolog, Protein,Sequence Homologies, Protein,Sequence Homologs, Protein

Related Publications

T Komai, and R Yagi, and H Suzuki-Sunagawa, and M Sakurai, and S Higashida, and M Sugano, and H Handa, and H Mohri, and A Yasuoka, and S Oka, and Y Yabe, and T Nishigaki, and S Kimura, and K Shimada
Practical synthesis of (2s,3s)-3-amino-2-hydroxy-4-phenylbutyric acid, a key component of HIV protease inhibitors.
April 1998, Chemical & pharmaceutical bulletin,
T Komai, and R Yagi, and H Suzuki-Sunagawa, and M Sakurai, and S Higashida, and M Sugano, and H Handa, and H Mohri, and A Yasuoka, and S Oka, and Y Yabe, and T Nishigaki, and S Kimura, and K Shimada
X-ray structure determination of (2S, 3R)-3-amino-2-hydroxy-4-phenylbutanoic acid, a new amino acid component of bestatin.
January 1976, The Journal of antibiotics,
T Komai, and R Yagi, and H Suzuki-Sunagawa, and M Sakurai, and S Higashida, and M Sugano, and H Handa, and H Mohri, and A Yasuoka, and S Oka, and Y Yabe, and T Nishigaki, and S Kimura, and K Shimada
2S,3R 3-amino-2-hydroxy-4-phenylbutanoic acid derivatives, enkephalinase inhibitors, augment met5-enkephalin-induced antinociception.
March 1988, Japanese journal of pharmacology,
T Komai, and R Yagi, and H Suzuki-Sunagawa, and M Sakurai, and S Higashida, and M Sugano, and H Handa, and H Mohri, and A Yasuoka, and S Oka, and Y Yabe, and T Nishigaki, and S Kimura, and K Shimada
Relationship between enhancement of morphine analgesia and inhibition of enkephalinase by 2S, 3R 3-amino-2-hydroxy-4-phenylbutanoic acid derivatives.
May 1982, Life sciences,
T Komai, and R Yagi, and H Suzuki-Sunagawa, and M Sakurai, and S Higashida, and M Sugano, and H Handa, and H Mohri, and A Yasuoka, and S Oka, and Y Yabe, and T Nishigaki, and S Kimura, and K Shimada
In vitro anti-human immunodeficiency virus (HIV) activities of transition state mimetic HIV protease inhibitors containing allophenylnorstatine.
April 1993, Antimicrobial agents and chemotherapy,
T Komai, and R Yagi, and H Suzuki-Sunagawa, and M Sakurai, and S Higashida, and M Sugano, and H Handa, and H Mohri, and A Yasuoka, and S Oka, and Y Yabe, and T Nishigaki, and S Kimura, and K Shimada
Ahpatinins, new acid protease inhibitors containing 4-amino-3-hydroxy-5-phenylpentanoic acid.
August 1986, The Journal of antibiotics,
T Komai, and R Yagi, and H Suzuki-Sunagawa, and M Sakurai, and S Higashida, and M Sugano, and H Handa, and H Mohri, and A Yasuoka, and S Oka, and Y Yabe, and T Nishigaki, and S Kimura, and K Shimada
Inhibitors of human immunodeficiency virus type 1 protease containing 2-aminobenzyl-substituted 4-amino-3-hydroxy-5-phenylpentanoic acid: synthesis, activity, and oral bioavailability.
May 1996, Journal of medicinal chemistry,
T Komai, and R Yagi, and H Suzuki-Sunagawa, and M Sakurai, and S Higashida, and M Sugano, and H Handa, and H Mohri, and A Yasuoka, and S Oka, and Y Yabe, and T Nishigaki, and S Kimura, and K Shimada
In vitro anti-human immunodeficiency virus (HIV) activity of XM323, a novel HIV protease inhibitor.
December 1993, Antimicrobial agents and chemotherapy,
T Komai, and R Yagi, and H Suzuki-Sunagawa, and M Sakurai, and S Higashida, and M Sugano, and H Handa, and H Mohri, and A Yasuoka, and S Oka, and Y Yabe, and T Nishigaki, and S Kimura, and K Shimada
Synthesis of (2S,3S)-[3-(2)H1]-4-methyleneglutamic acid and (2S,3R)-[2,3-(2)H2]-4-methyleneglutamic acid.
April 2006, Organic & biomolecular chemistry,
T Komai, and R Yagi, and H Suzuki-Sunagawa, and M Sakurai, and S Higashida, and M Sugano, and H Handa, and H Mohri, and A Yasuoka, and S Oka, and Y Yabe, and T Nishigaki, and S Kimura, and K Shimada
FR901724, a novel anti-human immunodeficiency virus (HIV) peptide produced by Streptomyces, shows synergistic antiviral activities with HIV protease inhibitor and 2',3'-dideoxynucleosides.
March 1996, Biological & pharmaceutical bulletin,
Copied contents to your clipboard!